NCT05056142

Brief Summary

The aim of this study is to compare the effect of epidural analgesia versus low-dose spinal analgesia in parturient in the late first stage of labor regarding time needed to perform the block, duration of the intra- and postoperative analgesia and incidence of procedure related adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 15, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 24, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

September 15, 2021

Last Update Submit

December 4, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The time to perform the block

    The time from the preparation of the block until the full injection of anesthetic drugs,

    Intraoperative

Secondary Outcomes (3)

  • Mean arterial blood pressure (MAP)

    Intraoperative

  • Heart rate (HR)

    Intraoperative

  • Number of participnts with Postoperative nausea and vomiting (PONV)

    First 24 hours postoperatively

Study Arms (2)

Epidural Anesthesia

ACTIVE COMPARATOR

Patients will receive epidural analgesia with 15 ml isobaric bupivacaine 0.125% plus fentanyl 2 μg/mL

Procedure: Epidural Anesthesia

Spinal Anesthesia

ACTIVE COMPARATOR

Patients will receive Spinal analgesia with 5 mg bupivacaine and 25 μg of fentanyl in a 2 ml volume.

Procedure: Spinal Analgesia

Interventions

Patients will receive epidural analgesia with 15 ml isobaric bupivacaine 0.125% plus fentanyl 2 μg/mL.

Epidural Anesthesia

Patients will receive Spinal analgesia with 5 mg bupivacaine and 25 μg of fentanyl in a 2 ml volume.

Spinal Anesthesia

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Parturient with normal vaginal delivery in late first stage of labor (cervical dilatation ≥ 6 cm by examination)
  • Aged 18-40 years old
  • Single, term pregnant with normal fetal heart rate
  • Request neuroaxial analgesia

You may not qualify if:

  • Parturient who refuses to participate,
  • American Society of Anesthesiologists (ASA) physical status \>II,
  • Body mass index more than 35 kg/m2
  • Severe pre-eclampsia or eclampsia
  • Uncontrolled thyrotoxicosis
  • Cardiovascular troubles (e.g. stenotic valvular heart disease or cardiomyopathy)
  • Increased intracranial tension due to a space-occupying lesion
  • Any contraindication to regional anesthesia such as local skin or soft tissue infection, coagulopathy or receiving anticoagulant therapy, thrombocytopenic, uncorrected hypovolemia, preexisting neurologic deficits, spinal deformity or previous spine surgery.
  • Hypersensitivity to the study drugs
  • Parturient who scheduled for emergency cesarean section due to fetal distress, antepartum hemorrhage, multiple gestation or fetal malpresentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University Hospitals

Cairo, Egypt

Location

MeSH Terms

Interventions

Anesthesia, Epidural

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 15, 2021

First Posted

September 24, 2021

Study Start

September 14, 2021

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

December 7, 2022

Record last verified: 2022-12

Locations